Metabolism Regulation by Estrogens and Their Receptors in the Central Nervous System before and after Menopause

Hormone and Metabolic Research

Volumn 48, Issue 8, 2016, Pages 489-496

  Coyoy, A ^a   Guerra Araiza, C ^b   Camacho Arroyo, I ^c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

diabetes; estrogens receptor; menopause; metabolic syndrome

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; INSULIN;

ABDOMINAL OBESITY; APPETITE; ARTICLE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; DYSLIPIDEMIA; ENERGY BALANCE; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MENOPAUSE; METABOLIC BALANCE; METABOLIC REGULATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SATIETY; ENERGY METABOLISM; FEMALE; METABOLISM;

CENTRAL NERVOUS SYSTEM; ENERGY METABOLISM; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; METABOLIC SYNDROME X; RECEPTORS, ESTROGEN;

EID: 84978091812     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0042-110320     Document Type: Article

References (107)

1. Grundy S. M. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol: 2008; 28 629 636
2. Grill H. J., Kaplan J. M. The neuroanatomical axis for control of energy balance. Front Neuroendocrinol: 2002; 23 2 40
3. Williams G., Bing C., Cai X. J., Harrold J. A., King P. J., Liu X. H. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav: 2001; 74 683 701
4. Xu Y., Nedungadi T. P., Zhu L., Sobhani N., Irani B. G., Davis K. E., Zhang X., Zou F., Gent L. M., Hahner L. D., Khan S. A., Elias C. F., Elmquist J. K., Clegg D. J. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab: 2011; 14 453 465
5. Salpeter S. R., Walsh J. M., Ormiston T. M., Greyber E., Buckley N. S., Salpeter E. E. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab: 2006; 8 538 554
6. Hart-Unger S., Korach K. S. Estrogens and obesity: is it all in our heads? Cell Metab: 2011; 14 435 436
7. Meirelles R. M. Menopause and metabolic syndrome. Arq Bras Endocrinol Metabol: 2012; 58 91 96
8. Jones M. E., Thorburn A. W., Britt K. L., Hewitt K. N., Wreford N. G., Proietto J., Oz O. K., Leury B. J., Robertson K. M., Yao S., Simpson E. R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA: 2000; 97 12735 12740
9. Nelson L. R., Bulun S. E. Estrogen production and action. J Am Acad Dermatol: 2001; 45 S116 S124
10. Shen Z., Saloniemi T., Rönnblad A., Järvensivu P., Pakarinen P., Poutanen M. Sex steroid-dependent and -independentmaction of hydroxysteroid (17β) dehydrogenase 2: evidence from transgenic female mice. Endocrinology: 2009; 150 4941 4949
11. Simons S. S. Jr., Edwards D. P., Kumar R. Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges. Mol Endocrinol: 2014; 28 173 182
12. Paterni I., Granchi C., Katzenellenbogen J. A., Minutolo F. Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential. Steroids: 2014; 90 13 29
13. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Ström A., Treuter E., Warner M., Gustafsson J. A. Estrogen receptors: how do they signal and what are their targets. Physiol Rev: 2007; 87 905 931
14. McDonnell D. P., Wardell S. E. The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer. Curr Opin Pharmacol: 2010; 10 620 628
15. Safe S., Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol: 2008; 41 263 275
16. Powell E., Xu W. Intermolecular interactions identify ligand-selective activity of estrogen receptor alpha/beta dimers. Proc Natl Acad Sci U S A: 2008; 105 19012 19017
17. Sutter-Dub M. T. Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte and other cell types. Steroids: 2002; 67 77 93
18. Foster T. C. Interaction of rapid signal transduction cascades and gene expression in mediating estrogen effects on memory over the life span. Front Neuroendocrinol: 2005; 26 51 64
19. Gingerich S., Kim G. L., Chalmers J. A., Koletar M. M., Wang X., Wang Y., Belsham D. D. Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models. Neuroscience: 2010; 170 54 66
20. Maruyama N. O., Lucas T. F., Porto C. S., Abdalla F. M. Estrogen receptor ESR1 regulates the phospholipase C-inositol phosphate signaling in the hippocampus from rats in proestrous and estrous phases. Steroids: 2013; 78 8 14
21. Wu T. W., Chen S., Brinton R. D. Membrane estrogen receptors mediate calcium signaling and MAP kinase activation in individual hippocampal neurons. Brain Res: 2011; 1379 34 43
22. Zhang Q. G., Raz L., Wang R., Han D., De Sevilla L., Yang F., Vadlamudi R. K., Brann D. W. Estrogen attenuates ischemic oxidative damage via an estrogen receptor α-mediated inhibition of NADPH oxidase activation. J Neurosci: 2009; 29 13823 13836
23. Clark S., Rainville J., Zhao X., Katzenellenbogen B. S., Pfaff D., Vasudevan N. Estrogen receptor-mediated transcription involves the activation of multiple kinase pathways in neuroblastoma cells. J Steroid Biochem Mol Biol: 2014; 139 45 53
24. Brinton R. D. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci: 2008; 31 529 537
25. Frank A., Brown L. M., Clegg D. J. The role of hypothalamic estrogen receptors in metabolic regulation. Front Neuroendocrinol: 2014; 35 550 557
26. Osterlund M., Kuiper G. G., Gustafsson J. A., Hurd Y. L. Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res Mol Brain Res: 1998; 54 175 180
27. Merchenthaler I., Lane M. V., Numan S., Dellovade T. L. Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses. J Comp Neurol: 2004; 473 270 291
28. Musatov S., Chen W., Pfaff D. W., Mobbs C. V., Yang X. J., Clegg D. J., Kaplitt M. G., Ogawa S. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA: 2007; 104 2501 2506
29. Barros R. P., Gustafsson JÅ. Estrogen receptors and the metabolic network. Cell Metab: 2011; 14 289 299
30. Ahdieh H. B., Wade G. N. Effects of hysterectomy on sexual receptivity, food intake, running wheel activity, and hypothalamic estrogen and progestin receptors in rats. J Comp Physiol Psychol: 1982; 96 886 892
31. Colvin G. B., Sawyer C. H. Induction of running activity by intracerebral implants of estrogen in ovariectomized rats. Neuroendocrinology: 1969; 4 309 320
32. Butera P. C., Czaja J. A. Intracranial estradiol in ovariectomized guinea pigs: effects on ingestive behaviors and body weight. Brain Res: 1984; 322 41 48
33. Park C. J., Zhao Z., Glidewell-Kenney C., Lazic M., Chambon P., Krust A., Weiss J., Clegg D. J., Dunaif A., Jameson J. L., Levine J. E. Genetic rescue of nonclassical ERalpha signaling normalizes energy balance in obese Erα-null mutant mice. J Clin Invest: 2011; 121 604 612
34. Otto C., Fuchs I., Kauselmann G., Kern H., Zevnik B., Andreasen P., Schwarz G., Altmann H., Klewer M., Schoor M., Vonk R., Fritzemeier K. H. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol Reprod: 2009; 80 34 41
35. Martensson U. E., Salehi S. A., Windahl S., Gomez M. F., Swärd K., Daszkiewicz-Nilsson J., Wendt A., Andersson N., Hellstrand P., Grände P. O., Owman C., Rosen C. J., Adamo M. L., Lundquist I., Rorsman P., Nilsson B. O., Ohlsson C., Olde B., Leeb-Lundberg L. M. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology: 2009; 150 687 698
36. Srivastava D. P., Evans P. D. G-protein oestrogen receptor 1: trials and tribulations of a membrane oestrogen receptor. J Neuroendocrinol: 2013; 25 1219 1230
37. Xu Y., Nedungadi T. P., Zhu L., Sobhani N., Irani B. G., Davis K. E., Zhang X., Zou F., Gent L. M., Hahner L. D., Khan S. A., Elias C. F., Elmquist J. K., Clegg D. J. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab: 2011; 14 453 465
38. Hirosawa M., Minata M., Harada K. H., Hitomi T., Krust A., Koizumi A. Ablation of estrogen receptor alpha (ERalpha) prevents up regulation of POMC by leptin and insulin. Biochem Biophys Res Commun: 2008; 371 320 323
39. Martínez de Morentin P. B., González-García I., Martins L., Lage R., Fernández-Mallo D., Martínez-Sánchez N., Ruíz-Pino F., Liu J., Morgan D. A., Pinilla L., Gallego R., Saha A. K., Kalsbeek A., Fliers E., Bisschop P. H., Diéguez C., Nogueiras R., Rahmouni K., Tena-Sempere M., López M. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metab: 2014; 20 41 53
40. Pelletier G., Li S., Luu-The V., Labrie F. Oestrogenic regulation of pro-opiomelanocortin, neuropeptide Y and corticotrophin-releasing hormone mRNAs in mouse hypothalamus. J Neuroendocrinol: 2007; 19 426 431
41. Ahima R. S., Bjorbaek C., Osei S., Flier J. S. Regulation of neuronal and glial proteins by leptin: implications for brain development. Endocrinology: 1999; 140 2755 2762
42. Elias C. F., Aschkenasi C., Lee C., Kelly J., Ahima R. S., Bjorbaek C., Flier J. S., Saper C. B., Elmquist J. K. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron: 1999; 23 775 786
43. Elmquist J. K., Elias C. F., Saper C. B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron: 1999; 22 221 232
44. Münzberg H., Morrison C. D. Structure, production and signaling of leptin. Metabolism: 2015; 64 13 23
45. Diano S., Kalra S. P., Sakamoto H., Horvath T. L. Leptin receptors in estrogen receptor- containing neurons of the female rat hypothalamus. Brain Res: 1998; 812 256 259
46. Burke M. C., Letts P. A., Krajewski S. J., Rance N. E. Coexpression of dynorphin and neurokinin B immunoreactivity in the rat hypothalamus: Morphologic evidence of interrelated function within the arcuate nucleus. J Comp Neurol: 2006; 498 712 726
47. Seminara S. B., Messager S., Chatzidaki E. E., Thresher R. R., Acierno J. S. Jr, Shagoury J. K., Bo-Abbas Y., Kuohung W., Schwinof K. M., Hendrick A. G., Zahn D., Dixon J., Kaiser U. B., Slaugenhaupt S. A., Gusella J. F., O'Rahilly S., Carlton M. B., Crowley W. F. Jr., Aparicio S. A., Colledge W. H. The GPR54 gene as a regulator of puberty. N Engl J Med: 2003; 349 1614 1627
48. Mittelman-Smith M. A., Williams H., Krajewski-Hall S. J., Lai J., Ciofi P., McMullen N. T., Rance N. E. Arcuate kisspeptin/neurokinin B/dynorphin (KNDy) neurons mediate the estrogen suppression of gonadotropin secretion and body weight. Endocrinology: 2012; 153 2800 2812
49. Oakley A. E., Clifton D. K., Steiner R. A. Kisspeptin signaling in the brain. Endocr Rev: 2009; 30 713 743
50. Smith J. T., Cunningham M. J., Rissman E. F., Clifton D. K., Steiner R. A. Regulation of Kiss1 gene expression in the brain of the female mouse. Endocrinology: 2005; 146 3686 3692
51. Pineda R., Garcia-Galiano D., Roseweir A., Romero M., Sanchez-Garrido M. A., Ruiz-Pino F., Morgan K., Pinilla L., Millar R. P., Tena-Sempere M. Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology: 2010; 151 722 730
52. Scott V., Brown C. H. Beyond the GnRH axis: kisspeptin regulation of the oxytocin system in pregnancy and lactation. Adv Exp Med Biol: 2013; 784 201 218
53. Della Torre S., Benedusi V., Fontana R., Maggi A. Energy metabolism and fertility-a balance preserved for female health. Nat Rev Endocrinol: 2014; 10 13 23
54. Titolo D., Cai F., Belsham D. D. Coordinate regulation of neuropeptide Y and agouti-related peptide gene expression by estrogen depends on the ratio of estrogen receptor (ER) alpha to ERbeta in clonal hypothalamic neurons. Mol Endocrinol: 2006; 20 2080 2092
55. Olofsson L. E., Pierce A. A., Xu A. W. Functional requirement of AgRP and NPY neurons in ovarian cycle-dependent regulation of food intake. Proc Natl Acad Sci USA: 2009; 106 15932 15937
56. Smith A. W., Bosch M. A., Wagner E. J., Ronnekleiv O. K., Kelly M. J. The membrane estrogen receptor ligand STX rapidly enhances GABAergic signaling in NPY/AgRP neurons: role in mediating the anorexigenic effects of 17beta-estradiol. Am J Physiol Endocrinol Metab: 2013; 305 E632 E640
57. Liang Y. Q., Akishita M., Kim S., Ako J., Hashimoto M., Iijima K., Ohike Y., Watanabe T., Sudoh N., Toba K., Yoshizumi M., Ouchi Y. Estrogen receptor beta is involved in the anorectic action of estrogen. Int J Obes Relat Metab Disord: 2002; 26 1103 1109
58. Foryst-Ludwig A., Clemenz M., Hohmann S., Hartge M., Sprang C., Frost N., Krikov M., Bhanot S., Barros R., Morani A., Gustafsson J. A., Unger T., Kintscher U. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet: 2008; 4 e1000108
59. Yepuru M., Eswaraka J., Kearbey J. D., Barrett C. M., Raghow S., Veverka K. A., Miller D. D., Dalton J. T., Narayanan R. Estrogen receptor-{beta}-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice. J Biol Chem: 2010; 285 31292 31303
60. Schuit S. C., Oei H. H., Witteman J. C., Geurts van Kessel C. H., van Meurs J. B., Nijhuis R. L., van Leeuwen J. P., de Jong F. H., Zillikens M. C., Hofman A., Pols H. A., Uitterlinden A. G. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA: 2004; 29 2969 2977
61. Lamon-Fava S., Asztalos B. F., Howard T. D., Reboussin D. M., Horvath K. V., Schaefer E. J., Herrington D. M. Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after horme therapy in postmenopausal women. Clin Endocrinol (Oxf): 2010; 72 169 175
62. Yoshihara R., Utsunomiya K., Gojo A., Ishizawa S., Kanazawa Y., Matoba K., Taniguchi K., Yokota T., Kurata H., Yokoyama J., Urashima M., Tajima N. Association of polymorphism of estrogen receptor-alpha gene with circulating levels of adiponectin in postmenopausal women with type 2 diabetes. J Atheroscler Thromb: 2009; 16 250 255
63. Eastwood H., Brown K. M., Markovic D., Pieri L. F. Variation in the ESR1 and ESR2 genes and genetic susceptibility to anorexia nervosa. Mol Psychiatry: 2002; 7 86 89
64. Peter I., Shearman A. M., Vasan R. S., Zucker D. R., Schmid C. H., Demissie S., Cupples L. A., Kuvin J. T., Karas R. H., Mendelsohn M. E., Housman D. E., Benjamin E. J. Association of estrogen receptor beta gene polymorphisms with left ventricular mass and wall thickness in women. Am J Hypertens: 2005; 18 1388 1395
65. Nilsson S., Gustafsson J. A. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther: 2011; 89 44 55
66. Goulart A. C., Zee R. Y., Pradhan A., Rexrode K. M. Associations of the estrogen receptors 1 and 2 gene polymorphisms with the metabolic syndrome in women. Metab Syndr Relat Disord: 2009; 7 111 117
67. Della Torre S., Rando G., Meda C., Stell A., Chambon P., Krust A., Ibarra C., Magni P., Ciana P., Maggi A. Amino acid-dependent activation of liver estrogen receptor alpha integrates metabolic and reproductive functions via IGF-1. Cell Metab: 2011; 13 205 214
68. Ribas V., Nguyen M. T., Henstridge D. C., Nguyen A. K., Beaven S. W., Watt M. J., Hevener A. L. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab: 2010; 298 E304 E319
69. Tiano J. P., Delghingaro-Augusto V., Le May C., Liu S., Kaw M. K., Khuder S. S., Latour M. G., Bhatt S. A., Korach K. S., Najjar S. M., Prentki M., Mauvais-Jarvis F. Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes. J Clin Invest: 2011; 121 3331 3342
70. Gao H., Bryzgalova G., Hedman E., Khan A., Efendic S., Gustafsson J. A., Dahlman-Wright K. Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol: 2006; 20 1287 1299
71. Cameron A. J., Shaw J. E., Zimmet P. Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am: 2004; 33 351 375
72. Palmer B. F., Clegg D. J. The sexual dimorphism of obesity. Mol Cell Endocrinol: 2015; 402 113 119
73. Morabia A., Costanza M. C. International variability in ages at menarche, first livebirth, and menopause. World Health Organization collaborative study of neoplasia and steroid contraceptives. Am J Epidemiol: 1998; 148 1195 1205
74. Awa W. L., Fach E., Krakow D., Welp R., Kunder J., Voll A., Zeyfang A., Wagner C., Schütt M., Boehm B., de Souza M., Holl R. W. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120 183 patients from the German/Austrian DPV database. Eur J Endocrinol: 2012; 167 245 254
75. Wietlisbach V., Marques-Vidal P., Kuulasmaa K., Karvanen J., Paccaud F. The relation of body mass index and abdominal adiposity with dyslipidemia in 27 general populations of the WHO MONICA Project. Nutr Metab Cardiovas Dis: 2013; 23 432 442
76. Clegg D. J. Minireview: the year in review of estrogen regulation of metabolism. Mol Endocrinol: 2012; 26 1957 1960
77. Nejat E. J., Chervenak J. L. The continuum of ovarian aging and clinicopathologies associated with the menopausal transition. Maturitas: 2010; 66 187 190
78. Roepke T. A. Oestrogen modulates hypothalamic control of energy homeostasis through multiple mechanisms. J Neuroendocrinol: 2009; 21 141 150
79. Lovejoy J. C., Champagne C. M., de Jonge L., Xie H., Smith S. R. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond): 2008; 32 949 958
80. Pallottini V., Bulzomi P., Galluzzo P., Martini C., Marino M. Estrogen regulation of adipose tissue functions: involvement of estrogen receptor isoforms. Infect Disord Drug Targets: 2008; 8 52 60
81. Taniguchi C. M., Emanuelli B., Kahn C. R. Critical nodes in signaling pathways: insights into insulin action. Nat Rev Mol Cell Biol: 2006; 7 85 96
82. Wolfe A., Divall S., Wu S. The regulation of reproductive neuroendocrine function by insulin and insulin-like growth factor-1 (IGF-1). Front Neuroendocrinol: 2014; 35 558 572
83. Shi J., Simpkins J. W. 17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am J Physiol: 1997; 272 E1016 E1022
84. Cheng C. M., Cohen M., Wang J., Bondy C. A. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB: 2001; 15 907 915
85. Mendez P., Wandosell F., Garcia-Segura L. M. Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Front Neuroendocrinol: 2006; 27 391 403
86. Zhao L., Morgan T. E., Mao Z., Lin S., Cadenas E., Finch C. E., Pike C. J., Mack W. J., Brinton R. D. Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles. PLoS One: 2012; 7 e31267
87. Jayaraman A., Carroll J. C., Morgan T. E., Lin S., Zhao L., Arimoto J. M., Murphy M. P., Beckett T. L., Finch C. E., Brinton R. D., Pike C. J. 17beta-Estradiol and progesterone regulate expression of beta-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology: 2012; 153 5467 5479
88. Nelson B., Springer R., Daniel J. Antagonism of brain insulin-like growth factor-1 receptors blocks estradiol effects on memory and levels of hippocampal synaptic proteins in ovariectomized rats. Psychopharmacology: 2014; 231 899 907
89. Witty C. F., Gardella L. P., Perez M. C., Daniel J. M. Short-term estradiol administration in aging ovariectomized rats provides lasting benefits for memory and the hippocampus: a role for insulin-like growth factor-I. Endocrinology: 2012; 154 842 852
90. Walton C., Godsland I. F., Proudler A. J., Wynn V., Stevenson J. C. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest: 1993; 23 466 473
91. Manrique C., Lastra G., Habibi J., Mugerfeld I., Garro M., Sowers J. R. Loss ofestrogen receptor alpha signaling leads to insulin resistance and obesity in young and adult female mice. Cardiorenal Med: 2012; 2 200 210
92. Zhu L., Brown W. C., Cai Q., Krust A., Chambon P., McGuinness O. P., Stafford J. M. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes: 2013; 62 424 434
93. Polotsky H. N., Polotsky A. J. Metabolic Implications of Menopause. Semin Reprod Med: 2010; 28 426 434
94. Munoz J., Derstine A., Gower B. A. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement. Obes Res: 2002; 10 424 431
95. Pickar J. H., Thorneycroft I., Whitehead M. Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995. Am J Obstet Gynecol: 1998; 178 1087 1099
96. Chmouliovsky L., Habicht F., James R. W., Lehmann T., Campana A., Golay A. Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas: 1999; 32 147 153
97. Salpeter S. R., Walsh J. M., Ormiston T. M., Greyber E., Buckley N. S., Salpeter E. E. Meta-analysis: effect of hormone replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab: 2006; 8 538 554
98. Manson J. E. Current recommendations: what is the clinician to do? Fertil Steril: 2014; 101 916 921
99. Cagnacci A., Renzi A., Cannoletta M., Pirillo D., Arangino S., Volpe A. Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women. Fertil Steril: 2006; 86 480 483
100. Boyanov M. A., Shinkov A. D. Effects of tibolone on body composition in postmenopausal women: a 1-year follow up study. Maturitas: 2005; 51 363 369
101. Manassiev N., Godsland I. F., Proudler A. J., Whitehead M. I., Stevenson J. C. Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism. Clin Endocrinol (Oxf): 2013; 78 297 302
102. Weigt C., Hertrampf T., Kluxen F. M., Flenker U., Hülsemann F., Fritzemeier K. H., Diel P. Molecular effects of ER alpha- and beta-selective agonists on regulation of energy homeostasis in obese female Wistar rats. Mol Cell Endocrinol: 2013; 377 147 158
103. Bonds D. E., Lasser N., Qi L., Brzyski R., Caan B., Heiss G., Limacher M. C., Liu J. H., Mason E., Oberman A., O'Sullivan M. J., Phillips L. S., Prineas R. J., Tinker L. The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia: 2006; 49 459 468
104. Crook D., Godsland I. F., Hull J., Stevenson J. C. Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. Br J Obstet Gynaecol: 1997; 104 298 304
105. Spencer C. P., Godsland I. F., Cooper A. J., Ross D., Whitehead M. I., Stevenson J. C. Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. Metabolism: 2000; 49 742 747
106. Shadoan M. K., Anthony M. S., Rankin S. E., Clarkson T. B., Wagner J. D. Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys. Metabolism: 2003; 52 1085 1091
107. Shadoan M. K., Kavanagh K., Zhang L., Anthony M. S., Wagner J. D. Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue. Metabolism: 2007; 56 830 837